about
Insulin receptorAdiponectin, C1Q and collagen domain containingGTP cyclohydrolase 1A disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 13CD14 antigenTumor necrosis factor receptor superfamily, member 11a, NFKB activatorCaspase 8Sphingosine kinase 1Janus kinase 2Chemokine (C-C motif) ligand 5GTP cyclohydrolase 1Receptor interacting serine/threonine kinase 1Tripartite motif containing 32Negative regulator of ubiquitin like proteins 1Mitogen-activated protein kinase kinase 7C-X-C motif chemokine ligand 16ADAM metallopeptidase domain 9ADAM metallopeptidase domain 10Gamma-glutamyltransferase 1Ribosomal protein S6 kinase B1AF4/FMR2 family member 3Chitinase 3 like 1Endonuclease GImmunoglobulin binding protein 1YTH domain containing 2Nicotinamide nucleotide adenylyltransferase 3Mitogen-activated protein kinase kinase kinase kinase 3Putative gamma-glutamyltranspeptidase 3Inactive gamma-glutamyltranspeptidase 2Chitinase-like 1A disintegrin and metallopeptidase domain 9 (meltrin gamma)Mitogen-activated protein kinase kinase 7Chemokine (C-C motif) ligand 2AF4/FMR2 family, member 3A disintegrin and metallopeptidase domain 10Tripartite motif-containing 32Receptor (TNFRSF)-interacting serine-threonine kinase 1Gamma-glutamyltransferase 1Mitogen-activated protein kinase kinase kinase kinase 3Chemokine (C-X-C motif) ligand 16
P682
Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectinE1-L2 activates both ubiquitin and FAT10Investigation of rheumatoid arthritis susceptibility genes identifies association of AFF3 and CD226 variants with response to anti-tumour necrosis factor treatmentThe role of CXCL16 and its processing metalloproteinases ADAM10 and ADAM17 in the proliferation and migration of human mesangial cellsCytokines stimulate GTP cyclohydrolase I gene expression in cultured human umbilical vein endothelial cellsIL-13 induces phosphorylation and activation of JAK2 Janus kinase in human colon carcinoma cell lines: similarities between IL-4 and IL-13 signalingThe UBA domains of NUB1L are required for binding but not for accelerated degradation of the ubiquitin-like modifier FAT10
P921
Q14863366-41C44E91-9A82-43C0-A14A-DE01CAAF4F06Q14864062-8B87D18A-F83E-4EA2-A9A8-0144887AC800Q1487359-2E64ED7D-604E-458F-BAB8-236E6E4AD67BQ14873947-3895CE91-982B-4738-AC72-B7ABF4762055Q14887528-095AA420-0052-4BC0-B116-199CA298F653Q14900987-6929D122-B2FF-4540-91E0-D37C556E5120Q14911968-7503DAA0-F5A3-439F-9AE2-86F1BDF43098Q14913839-1EDDE7B8-1F68-4FBF-9E6E-6254CD034C88Q14913839-45281F10-6F01-40AA-BF2C-CD0CE9DBC133Q14914518-CAC5751C-8793-4E7A-850F-BE41B72A79F9Q14916107-A0E5497E-B94F-4589-A3D0-82C4BBA836FEQ14916170-B609D026-E0B8-4914-9377-B0ED1DDEBB9FQ21101871-ABB22DCE-7266-4033-A883-1ED70BB3C671Q21104807-14B43B55-6F56-4B09-950F-A63E55EFBEBEQ21105114-0C8EBE76-C3E6-4374-83AA-565B3BAC59ACQ21109744-F59E1ED4-C3AB-4315-89AC-74F2342E0D4BQ21112082-741B5651-F567-4849-8190-CF4AF6607E59Q21113741-26C38C39-4BC8-4B22-96CF-5F9E5573D7F0Q21113783-923BD8D2-7A4D-40FE-ABCA-62E0B5A02FA8Q21114607-AA03773D-58FA-43B9-96C8-7E9D503F322CQ21114975-1C9A5427-DC49-4C08-A899-F03BEC27319DQ21116353-481D2167-54B2-4CFE-8AEC-C7DD0DCA6536Q21117210-9F4264CB-5B1D-47BA-A2EE-CB1E5869372EQ21117957-EA076B06-F6E5-4ACC-917B-124CDD2029CFQ21118373-582F36AA-E2F1-40D5-BFAC-1D81984097B8Q21118457-BDFC777A-0041-4B24-A455-7B1892531E53Q21118870-FEDEAD53-6035-44E6-B794-FB32666FC0EFQ21130664-17CC38B9-493A-4A1B-8091-3A84D8988E1AQ21132643-823C5B29-8DE6-44F3-B6BD-5034B51C688AQ21173469-C9B0060F-4445-4235-BA28-899C4D857A13Q21494180-D5E9FF6B-D7DB-4F4A-8743-374C8C48EB84Q21495348-6A703CAB-8A7A-4F38-B968-CF43EA1FF3B1Q21495348-9B11E5A4-4818-4478-8B7F-8A78337CC1FDQ21495986-80EB9E03-E36A-48FE-B794-07AEFBCFFF42Q21496220-962B5E97-6364-4A36-AB09-277ACA4552B6Q21496854-E4AAB170-C7CE-43E4-AB49-9711552A1AB8Q21498822-766A0D1D-9A7E-4786-9FE2-7C6FA98177D9Q21498896-8D8BBBC2-2D94-4BA5-9DF6-BD088180EF31Q21981433-BB7BD7ED-3F79-4CE8-94A2-03BD7345F215Q21982090-9D5481DD-DC89-459C-872B-FC21850E669A
P682
Q22010955-D1DE9381-F7A9-4AA9-92B8-98A1A5235F8BQ24294748-9B13A944-4645-45FA-AA5D-16D94670BE2DQ24310184-F1B6E5BC-7308-4663-AABE-C6572CE2049AQ24315412-15855874-37EF-429C-B9AB-FA8D85B5A0A2Q24323362-A2457FA6-8B7F-427D-A848-3823E9A39ED2Q24324453-69256947-0246-40AE-8537-9807BC3AF9A3Q24337252-F397B643-391D-4D9D-83D7-1A94AC501671
P921
description
Any process that results in a ...... umor necrosis factor stimulus.
@en
biologisch proces
@nl
name
response to tumor necrosis factor
@en
type
label
response to tumor necrosis factor
@en
altLabel
GO:0034612
@en
response to TNF
@en
prefLabel
response to tumor necrosis factor
@en
P2888
P686
GO:0034612